Increased guanylate cyclase activity is associated with an increase in cyclic guanosine 3',5'-monophosphate in left ventricular hypertrophy.

Ítems similars

• Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations
  per: Arnold, William P., et al.
  Publicat: (1977)
• Natriuretic peptides and cyclic guanosine 3',5'-monophosphate in asymptomatic and symptomatic left ventricular dysfunction.
  per: Friedl, W., et al.
  Publicat: (1996)
• Nitric oxide — soluble guanylate cyclase — cyclic guanosine monophosphate signaling pathway in the pathogenesis of heart failure and search for novel therapeutic targets
  per: Zh. D. Kobalava, et al.
  Publicat: (2021-10-01)
• Identification of downstream target genes regulated by the nitric oxide–soluble guanylate cyclase–cyclic guanosine monophosphate signal pathway in pulmonary hypertension
  per: Zou, Lihui, et al.
  Publicat: (2016)
• Tissue Guanosine-3′,5′-Cyclic Monophosphate Levels and Soluble Guanylate Cyclase Activity: A POSITIVE CORRELATION DURING UNILATERAL CRYPTORCHIDISM IN THE RAT TESTIS
  per: Spruill, W. Austin, et al.
  Publicat: (1978)